Sepha sees growing demand for cost saving testing tech

By Gareth Macdonald

- Last updated on GMT

Related tags Bric Investment

The drug industry's need to improve product quality while reducing production costs is driving global demand for testing technologies according to Sepha.

The privately-equity backed Belfast firm - which does not publish its quarterly results - made the comments after reporting ‘record’ sales for its range of non-destructive leak testing and de-blistering equipment.

Company head of sales and marketing Paul Kelly called from P-Mec India in Mumbai – the regional launch site for Sepha’s VisionScan leak testing system– to explain that the recent growth was driven by higher demand in all the countries in which the firm operates.

We are an export dominated business,“ ​ Kelly said adding that “last year the main drivers were large manufacturers in North America and Europe, perhaps surprisingly given the current economic climate​.”

However,”​ he continued “we’ve also seen growth in the BRIC countries – Brazil, Russia, India China​” explaining that Serpha’s business in China is primarily dominated by multinational pharmaceutical companies investing in local manufacturing capacity.

In Brazil it’s more of a mix with global multinationals like Novartis and local generic players like Eurofarma​,” said Kelly. He added that the region’s rapidly expanding contract pharmaceutical packaging sector has also driven demand.

This growing demand for testing technologies in emerging markets fits with what Sepha spokeswoman Sarah Hession told in April ahead of VisionScan’s European launch​.

We have already received considerable interest in this machine [VisionScan] most notably from major pharmaceutical manufacturers in India​,” she said, adding that the system had attracted particular interest from generic manufacturers in emerging markets.

R&D investment

Sepha plans to capitalise on this increase in demand – and the higher revenues it has generated – and invest in developing the next generation of leak testing platforms according to Kelly.

We plan to develop additional leak detection equipment as well as de-blistering technologies with the flexibility that multinational drugmakers, generic manufacturers and contract manufacturing organisations demand​.”

Related news

Show more

Related products

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 04-May-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us


View more